Discontinued — last reported Q4 '23
Zoetis International — D&A remained flat by 0.0% to $23.00M in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 7.0%, from $21.50M to $23.00M. Over 2 years (FY 2021 to FY 2023), International — D&A shows an upward trend with a 11.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests higher capital investment or asset base expansion, while a decrease may indicate aging assets or reduced capital expenditure.
This metric represents the non-cash expense allocated to the International segment for the wear and tear of tangible ass...
Comparable to depreciation and amortization charges reported by global pharmaceutical or life sciences companies for specific geographic segments.
zts_segment_international_depreciation_depletion_and_amortization| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $74.00M | $86.00M | $92.00M |
| YoY Change | — | +16.2% | +7.0% |